Next Article in Journal
Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors
Next Article in Special Issue
Tumor Immune Microenvironment in Gynecologic Cancers
Previous Article in Journal
Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase®, the WHO Pharmacovigilance Database
Previous Article in Special Issue
Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma
 
 
Review

Article Versions Notes

Cancers 2023, 15(7), 2042; https://doi.org/10.3390/cancers15072042
Action Date Notes Link
article pdf uploaded. 29 March 2023 14:20 CEST Version of Record https://www.mdpi.com/2072-6694/15/7/2042/pdf-vor
article xml uploaded. 30 March 2023 07:07 CEST Original file -
article pdf uploaded. 30 March 2023 07:07 CEST Updated version of record https://www.mdpi.com/2072-6694/15/7/2042/pdf-vor
article html file updated 30 March 2023 07:09 CEST Original file -
article xml uploaded. 30 March 2023 07:39 CEST Update -
article pdf uploaded. 30 March 2023 07:39 CEST Updated version of record https://www.mdpi.com/2072-6694/15/7/2042/pdf-vor
article html file updated 30 March 2023 07:40 CEST Update -
article xml uploaded. 30 March 2023 07:54 CEST Update -
article pdf uploaded. 30 March 2023 07:54 CEST Updated version of record https://www.mdpi.com/2072-6694/15/7/2042/pdf-vor
article html file updated 30 March 2023 07:55 CEST Update -
article xml uploaded. 6 April 2023 11:28 CEST Update https://www.mdpi.com/2072-6694/15/7/2042/xml
article pdf uploaded. 6 April 2023 11:28 CEST Updated version of record https://www.mdpi.com/2072-6694/15/7/2042/pdf
article html file updated 6 April 2023 11:29 CEST Update -
article html file updated 6 April 2023 23:33 CEST Update https://www.mdpi.com/2072-6694/15/7/2042/html
Back to TopTop